Category: GE Healthcare
Hill-Rom looks to the energy industry for its new CEO, Steven Strobel, lured from retail energy services company BlueStar Energy.
Hill-Rom Holdings (NYSE:HRC) said it looked to the energy industry to replace James Saccaro as CFO, naming BlueStar Energy's former CFO Steven Strobel to the position.
, Dubilier & Rice
, Hansen Medical Inc.
, Hill-Rom Holdings Inc.
, Sotera Wireless
, Spine Wave
, GE Healthcare
Here's a look at some of the top Wall Street stories for medical device companies this week: 5 factors affecting the future of medtech; Medtech VC deals post double-digit increases in Q3; Breast implant maker Sientra sets IPO range; GE CEO Immelt: Global experience got Flannery the top spot at GE Healthcare; GI Dynamics proposes 1-for-10 reverse stock split
John Flannery's experience in global markets landed him the top spot at GE Healthcare, where he replaced John Dineen, GE CEO Jeffrey Immelt told analysts last week.
General Electric names its top M&A executive, John Flannery, to be the new president & CEO of its GE Healthcare business.
NEW YORK (Reuters) – GE (NYSE:GE) today named its top deal-making executive as head of its healthcare business, saying that the unit's prior chief is leaving the company.
Here's a look at some of the top legal news stories for medical device companies this week: GE Healthcare says engineer sent trade secrets to China; Counterclaims stand in whistleblower lawsuit against Boston Scientific; Boston Scientific loses $74M pelvic mesh verdict; DoJ says recorded meeting uncovers kickback scheme at Reliance Medical; Allergan caves to shareholder meeting after Valeant, Ackman rally support
GE Healthcare accuses one of its Wisconsin-based engineers of copying millions of confidential files before landing a job at a rival company in China.
Officials at GE Healthcare (NYSE:GE) filed a lawsuit against one of their Waukesha, Wisc., engineers after finding out that he copied millions of sensitive files that the company says were not necessary for his role.
GE Healthcare wins FDA approval for its SenoClaire 3D breast tomosynthesis system, a device that could displace digital mammography as the major technology for breast cancer screening.
Imaging giant GE Healthcare (NYSE:GE) won FDA approval for its 3D breast tomosynthesis imaging system, MassDevice.com has learned.